Figure 5.
Mean ± SE (A) mGH and (B) IGF-I by visit during the extension, in all patients and by previous first-generation SSA treatment. Reference line is (A) 1.0 μg/L and (B) ULN.
Mean ± SE (A) mGH and (B) IGF-I by visit during the extension, in all patients and by previous first-generation SSA treatment. Reference line is (A) 1.0 μg/L and (B) ULN.